Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-01 Sale |
2022-11-03 9:06 pm |
LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Former Director Director |
1,004 | $0 | $0 | 2,892 (Direct) |
View |
| 2022-09-16 Sale(A) |
2022-09-22 8:32 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
1,000 | $88.06 | $88,060 | 366,180 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-16 7:49 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
5,000 | $89.61 | $448,050 | 364,180 (Direct) |
View |
| 2022-05-13 Purchase |
2022-05-13 7:05 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
2,500 | $82.76 | $206,910 | 173,354 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-01 4:34 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
908 | $102.62 | $93,179 | 41,209 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-17 5:06 pm |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
4,835 | $161.86 | $782,579 | 25,398 (Direct) |
View |
| 2021-11-12 Sale |
2021-11-12 7:31 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
3,000 | $160.5 | $481,500 | 335,095 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-11-01 Option Award |
2022-11-03 9:05 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
45,922 | $0 | 424,731 (Direct) |
View |
Ownership |
2022-09-30 7:59 pm |
N/A N/A |
OmniAb Inc. | LIGAND PHARMACEUTICALS INC 10% Owner |
0 | $0 | 1,000 (Direct) |
View | |
| 2022-06-30 Other |
2022-07-06 8:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
164 | $75.84 | 52,696 (Direct) |
View |
| 2022-06-30 Other |
2022-07-06 8:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
164 | $75.84 | 369,344 (Direct) |
View |
| 2022-06-29 Option Award |
2022-06-30 6:32 pm |
N/A 2032-06-29 |
LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director |
7,657 | $0 | 7,657 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
5,375 | $0 | 35,769 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
9,137 | $0 | 182,491 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
20,423 | $0 | 369,016 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:54 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
8,062 | $0 | 52,368 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 3:56 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
5,344 | $0 | 33,674 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 6:47 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
5,344 | $0 | 130,627 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 6:47 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director |
5,344 | $0 | 8,236 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 6:47 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Cochran Jennifer R. Director |
5,344 | $0 | 6,505 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 6:46 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
5,344 | $0 | 56,126 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 6:46 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
5,344 | $0 | 9,046 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 6:45 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
5,344 | $0 | 46,553 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 6:45 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
5,344 | $0 | 30,742 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 6:45 pm |
N/A 2032-06-10 |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
5,344 | $0 | 34,164 (Direct) |
View |
| 2022-05-09 Exercise |
2022-05-10 5:33 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
8,000 | $0 | 1,131,209 (Direct) |
View |
| 2022-05-09 Exercise |
2022-05-10 5:33 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
8,000 | $21.92 | 1,131,209 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-09 8:10 pm |
N/A 2032-05-05 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
20,126 | $0 | 20,126 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-09 8:10 pm |
N/A 2032-05-05 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
30,189 | $0 | 30,189 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-09 8:10 pm |
N/A 2032-05-05 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
34,214 | $0 | 34,214 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-09 8:09 pm |
N/A 2032-05-05 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
76,478 | $0 | 76,478 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 4:34 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
7,335 | $12.53 | 41,209 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 4:34 pm |
N/A 2022-05-31 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
7,335 | $0 | 41,209 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-16 8:24 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
1,578 | $123.68 | 30,394 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-16 8:24 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
3,546 | $123.68 | 170,854 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-16 8:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
5,923 | $123.68 | 340,593 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-16 8:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
3,407 | $123.68 | 44,306 (Direct) |
View |
| 2021-11-15 Ownership |
2022-02-07 7:29 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
2,502 | $0 | 332,593 (Direct) |
View |
| 2022-01-26 Tax Withholding |
2022-01-28 8:43 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
3,628 | $113.68 | 47,713 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 8:43 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
11,651 | $0 | 47,713 (Direct) |
View |
| 2022-01-26 Tax Withholding |
2022-01-28 8:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
9,243 | $113.68 | 349,018 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 8:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
23,166 | $0 | 349,018 (Direct) |
View |
| 2022-01-26 Tax Withholding |
2022-01-28 8:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
2,156 | $113.68 | 31,972 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 8:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
6,237 | $0 | 31,972 (Direct) |
View |
| 2022-01-26 Tax Withholding |
2022-01-28 8:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
5,125 | $113.68 | 174,400 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 8:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
13,000 | $0 | 174,400 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 5:06 pm |
N/A 2023-06-11 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
4,835 | $0 | 25,398 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 5:06 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
4,835 | $32.3 | 25,398 (Direct) |
View |